FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase I trial is studying the side effects and best dose of FR901228 in treating
children with refractory or recurrent solid tumors or leukemia. Drugs used in chemotherapy
use different ways to stop cancer cells from dividing so they stop growing or die